Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

Tim Kanters; I Hoogenboom-Plug; Maureen Rutten - van Molken; Ken Redekop; Ans van der Ploeg; Leona Hakkaart - van Roijen

doi:10.1186/1750-1172-9-75

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

Pediatrics

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

28 Citations (Scopus)

43 Downloads (Pure)

Original language	English
Article number	75
Pages (from-to)	75
Journal	Orphanet Journal of Rare Diseases
Volume	9
DOIs	https://doi.org/10.1186/1750-1172-9-75
Publication status	Published - 2014

Research programs

EMC NIHES-05-63-02 Quality
EMC MM-01-54-01

Access to Document

10.1186/1750-1172-9-75

OABMC_1750-1172-9-75.pdfFinal published version, 525 KB

http://hdl.handle.net/1765/61607

Cite this

@article{f5d8800ce93a46e0adc7ad6ab90b53bc,

title = "Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease",

author = "Tim Kanters and I Hoogenboom-Plug and \{Rutten - van Molken\}, Maureen and Ken Redekop and \{van der Ploeg\}, Ans and \{Hakkaart - van Roijen\}, Leona",

year = "2014",

doi = "10.1186/1750-1172-9-75",

language = "English",

volume = "9",

pages = "75",

journal = "Orphanet Journal of Rare Diseases",

issn = "1750-1172",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

AU - Kanters, Tim

AU - Hoogenboom-Plug, I

AU - Rutten - van Molken, Maureen

AU - Redekop, Ken

AU - van der Ploeg, Ans

AU - Hakkaart - van Roijen, Leona

PY - 2014

Y1 - 2014

U2 - 10.1186/1750-1172-9-75

DO - 10.1186/1750-1172-9-75

M3 - Article

C2 - 24884717

SN - 1750-1172

VL - 9

SP - 75

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

M1 - 75

ER -